Fluvoxamine in the treatment of anxiety disorders.

Fluvoxamine in the treatment of anxiety disorders.

Item
http://www.wikidata.org/entity/Q36713425
Chronic antidepressant treatment impairs the acquisition of fear extinction.Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.Management of obsessive-compulsive disorder with fluvoxamine extended releaseEffectiveness of cognitive behavioral therapy and fluoxetine on sexual function of women with obsessive compulsive disorder: A double-blind randomized controlled trial.Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder.Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear.The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor.Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder.Early Life Stress, Depression And Parkinson's Disease: A New Approach.
P2860

Fluvoxamine in the treatment of anxiety disorders.

Item
http://www.wikidata.org/entity/Q36713425
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Fluvoxamine in the treatment of anxiety disorders.
@ast
Fluvoxamine in the treatment of anxiety disorders.
@en
type
label
Fluvoxamine in the treatment of anxiety disorders.
@ast
Fluvoxamine in the treatment of anxiety disorders.
@en
prefLabel
Fluvoxamine in the treatment of anxiety disorders.
@ast
Fluvoxamine in the treatment of anxiety disorders.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
Fluvoxamine in the treatment of anxiety disorders
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932